LAVA Therapeutics NV

NASDAQ:LVTX   12:54:49 PM EDT
6.31
-0.03 (-0.47%)
Earnings Announcements

Lava Therapeutics Reports Cash Balance of $151 Million

Published: 08/16/2021 11:45 GMT
LAVA Therapeutics NV (LVTX) - Lava Therapeutics Provides Business Update and Reports Second Quarter Results.
Lava Therapeutics NV - Cash Balance of $151 Million Expected to Fund Operations Into Second Half of 2023.
Lava Therapeutics NV Qtrly Loss per Share EUR 0.23.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.